Phase 2 Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL) Clinical Trials

1 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–1 of 1 trials

Recruiting

Phase 1Phase 2

The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

AML (Acute Myelogenous Leukemia)Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)

Tianjin Medical University General Hospital90 enrolled1 locationNCT06911710